These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9672842)

  • 1. Differences in extracellular matrix components and cell density during normal and dexamethasone-treated secondary palate development in two strains of mice with different susceptibility to glucocorticoid induced-clefting.
    Montenegro MA; Rojas M; Dominguez S; Rosales CJ
    J Craniofac Genet Dev Biol; 1998; 18(2):100-6. PubMed ID: 9672842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin, vimentin and E-cadherin immunodetection in the embryonic palate in two strains of mice with different susceptibility to glucocorticoid-induced clefting.
    Montenegro MA; Rojas M; Dominguez S; Vergara A
    J Craniofac Genet Dev Biol; 2000; 20(3):137-43. PubMed ID: 11321598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in collagen and cell density during normal and dexamethasone-treated secondary palate development in two strains of mice.
    Montenegro MA; Rojas M; Dominguez S; Posada J
    Int J Dev Biol; 1996; Suppl 1():245S-246S. PubMed ID: 9087781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular and molecular differences in cleft palate susceptibility in mice].
    Montenegro MA; Domínguez S; Palomino H
    Rev Med Chil; 1995 Mar; 123(3):283-91. PubMed ID: 8525166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus.
    Tocco DR; Renskers K; Zimmerman EF
    Teratology; 1987 Jun; 35(3):439-45. PubMed ID: 3629520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extracellular matrix infrastructure provides support for murine secondary palatal shelf remodelling.
    Morris-Wiman J; Brinkley L
    Anat Rec; 1992 Dec; 234(4):575-86. PubMed ID: 1280922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some new aspects of dexamethasone-induced cleft palate in mice.
    Sauerbier I
    Anat Anz; 1987; 163(4):319-22. PubMed ID: 3631525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal changes associated with retinoic acid induced cleft palate in CD-1 mice.
    Degitz SJ; Francis BM; Foley GL
    J Craniofac Genet Dev Biol; 1998; 18(2):88-99. PubMed ID: 9672841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive stages and dose-response analyses of palatal slit and cleft palate in C57BL/6 mice treated with a glucocorticoid.
    Kusanagi T
    Teratology; 1984 Apr; 29(2):281-6. PubMed ID: 6740512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palatal width growth rates as the genetic determinant of cleft palate induced by vitamin A.
    Siegel MI; Mooney MP
    J Craniofac Genet Dev Biol Suppl; 1986; 2():187-91. PubMed ID: 3491112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences between C57BL/6 and SWV mice in time of palate closure and induction of palatal slit and cleft palate.
    Kusanagi T
    Teratology; 1985 Apr; 31(2):279-83. PubMed ID: 3992497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse palatal width growth rates as an "at risk" factor in the development of cleft palate induced by hypervitaminosis A.
    Vergato LA; Doerfler RJ; Mooney MP; Siegel MI
    J Craniofac Genet Dev Biol; 1997; 17(4):204-10. PubMed ID: 9493079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.
    Erickson RP; Cao W; Acuña DK; Strnatka DW; Hunter RJ; Chau BT; Wakefield LV; Sim E; McQueen CA
    Mol Reprod Dev; 2008 Jun; 75(6):1071-6. PubMed ID: 18161794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of decorin and biglycan genes during palatogenesis in normal and retinoic acid-treated mice.
    Zhang Y; Mori T; Iseki K; Hagino S; Takaki H; Takeuchi M; Hikake T; Tase C; Murakawa M; Yokoya S; Wanaka A
    Dev Dyn; 2003 Apr; 226(4):618-26. PubMed ID: 12666199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chlorcyclizine-induced glycosaminoglycan alterations on palatal mesenchyme-basal lamina relationships in the mouse.
    Brinkley LL; Morris-Wiman J
    Am J Anat; 1986 Jul; 176(3):379-89. PubMed ID: 2874737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced cleft palate in short-ear mice.
    Marazita ML; Jaskoll T; Melnick M
    J Craniofac Genet Dev Biol; 1988; 8(1):47-51. PubMed ID: 3209678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad2/3 is involved in growth inhibition of mouse embryonic palate mesenchymal cells induced by all-trans retinoic acid.
    Wang M; Huang H; Chen Y
    Birth Defects Res A Clin Mol Teratol; 2009 Sep; 85(9):780-90. PubMed ID: 19388084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic independence of the embryonic reactivity difference to cortisone- and 6-aminonicotinamide-induced cleft palate in the mouse.
    Biddle FG; Fraser FC
    Teratology; 1979 Apr; 19(2):207-11. PubMed ID: 157557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glucocorticoid receptor in fetal mouse: its relationship to cleft palate formation.
    Hackney JF
    Teratology; 1980 Feb; 21(1):39-51. PubMed ID: 7385055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secalonic acid D-induced changes in palatal cyclic AMP and cyclic GMP in developing mice.
    Eldeib MM; Reddy CS
    Teratology; 1988 Apr; 37(4):343-52. PubMed ID: 2839909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.